These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


615 related items for PubMed ID: 1918136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH, de Bart AC, Schalken JA, Verheijen JH.
    Prostate; 1997 Aug 01; 32(3):196-204. PubMed ID: 9254899
    [Abstract] [Full Text] [Related]

  • 3. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.
    Reiter LS, Kruithof EK, Cajot JF, Sordat B.
    Int J Cancer; 1993 Feb 01; 53(3):444-50. PubMed ID: 8381394
    [Abstract] [Full Text] [Related]

  • 4. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ, Kitson JL, Silvers WK, Mintz B.
    Cancer Res; 1995 Oct 15; 55(20):4681-7. PubMed ID: 7553649
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
    de Vries TJ, Quax PH, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GN.
    Am J Pathol; 1994 Jan 15; 144(1):70-81. PubMed ID: 8291613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
    Quax PH, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJ, Kuiper J, Emeis JJ.
    J Biol Chem; 1990 Sep 15; 265(26):15560-3. PubMed ID: 2118527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH, van Leeuwen RT, Verspaget HW, Verheijen JH.
    Cancer Res; 1990 Mar 01; 50(5):1488-94. PubMed ID: 2105839
    [Abstract] [Full Text] [Related]

  • 13. Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
    Tran-Thang C, Vouillamoz D, Kruithof EK, Sordat B.
    J Cell Physiol; 1994 Nov 01; 161(2):285-92. PubMed ID: 7962113
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
    Boxman IL, Quax PH, Löwik CW, Papapoulos SE, Verheijen J, Ponec M.
    J Invest Dermatol; 1995 Mar 01; 104(3):374-8. PubMed ID: 7861005
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M, García DC, Jiménez-Díaz M, Valdecantos PA, Miceli DC.
    Anim Reprod Sci; 2012 Dec 01; 136(1-2):90-9. PubMed ID: 23103014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.